Evolution of the HIV-1 integration site landscape and inducible reservoir in early-treated people

早期接受治疗人群中 HIV-1 整合位点格局和诱导性病毒库的演变

阅读:16
作者:Tine Struyve ,Marion Pardons ,Jozefien De Clercq ,Liesbet Termote ,Laurens Lambrechts ,Ytse Noppe ,Mathias Lichterfeld ,Sofie Rutsaert ,Linos Vandekerckhove

Abstract

Persistence of the HIV-1 reservoir is the major barrier to a cure. Little is known about the dynamics of the proviral integration site landscape and inducibility of the viral reservoir in early-treated individuals. Here, we perform a longitudinal analysis of the viral reservoir in individuals who started treatment during acute infection and compare these findings to chronically-treated individuals. Even in early-treated individuals, clonal expansion contributes to reservoir persistence. Integration site analysis reveals similar distributions after one year of antiretroviral therapy (ART), irrespective of treatment initiation timing. Notably, proviruses integrated in heterochromatin regions are already detected in early-treated individuals after one year on ART and are progressively enriched after five years on ART, suggesting post-integration selection mechanisms. Using a lipid nanoparticle containing Tat mRNA (Tat-LNP) in combination with phorbol myristate acetate (PMA), we detect for the first time the inducible reservoir in individuals treated during acute infection with small reservoir sizes. Furthermore, we show that, in both the acute and chronic cohorts, the inducible reservoir shifts towards a more differentiated T cell compartment over time. Collectively, these findings indicate that clonal expansion and integration site selection contribute to reservoir persistence early after ART initiation in individuals treated shortly after seroconversion.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。